Publications by authors named "Kevin Petty"

Claim this Profile
P
Pharmacokinetics and safety of golimumab in healthy Chinese subjects following a single subcutaneous administration in a randomized phase I trial.
Yanli Zhuang, Sally Lyn, Yuan Lv, Zhenhua Xu, Esther Bouman-Thio, Kevin J Petty

Clin Drug Investig· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo- and amitriptyline-controlled evaluation of central nervous system effects of the NK1 receptor antagonist aprepitant and intravenous alcohol infusion at pseudo-steady state.
Erik T te Beek, Daniel Tatosian, Anup Majumdar, Diana Selverian, Erica S Klaassen, Kevin J Petty

J Clin Pharmacol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study.
Bart van Hartingsveldt, Ivo P Nnane, Esther Bouman-Thio, Matthew J Loza, Alexa Piantone, Kevin J Petty

Br J Clin Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the pharmacokinetics of subcutaneous ustekinumab between Chinese and non-Chinese healthy male subjects across two Phase 1 studies.
Yaowei Zhu, Qingmin Wang, Bart Frederick, Esther Bouman-Thio, Joseph C Marini, Kevin J Petty

Clin Drug Investig· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjects.
Yanli Zhuang, Zhenhua Xu, Dick E de Vries, Qingmin Wang, Akira Shishido, Kevin J Petty

Int J Clin Pharmacol Ther· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway.
Marc A Judson, Richard M Marchell, MaryAnn Mascelli, Alexa Piantone, Elliot S Barnathan, Kevin J Petty

J Am Acad Dermatol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized study.
Yanli Zhuang, Zhenhua Xu, Bart Frederick, Dick E de Vries, Joyce A Ford, Kevin J Petty

Clin Ther· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant.
S Aubrey Stoch, Cynthia Gargano, Jack Valentine, Matthew P Braun, M Gail Murphy, Kevin J Petty

Cancer Chemother Pharmacol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sputum induction with hypertonic saline reduces fractional exhaled nitric oxide in chronic smokers and non-smokers.
Rob G J A Zuiker, Johan D Boot, Cesar Calderon, Alexa Piantone, Kevin Petty

Respir Med· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.
John R Atack, Karen A Maubach, Keith A Wafford, Desmond O'Connor, A David Rodrigues, Kevin J Petty

J Pharmacol Exp Ther· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of aprepitant on the pharmacokinetics of intravenous midazolam.
Anup K Majumdar, Kerri X Yan, Diana V Selverian, Suna Barlas, Marvin Constanzer, Kevin J Petty

J Clin Pharmacol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of aprepitant on hydrodolasetron pharmacokinetics in CYP2D6 extensive and poor metabolizers.
Susie Xiujiang Li, Edward Pequignot, Deborah Panebianco, Paul Lupinacci, Anup Majumdar, Kevin J Petty

J Clin Pharmacol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers.
Anup K Majumdar, Laura Howard, Michael R Goldberg, Lisa Hickey, Marvin Constanzer, Kevin J Petty

J Clin Pharmacol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitant.
Arthur J Bergman, Thomas Marbury, Trisha Fosbinder, Suzanne Swan, Lisa Hickey, Kevin J Petty

Clin Pharmacokinet· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients.
Peter Nygren, Kenneth Hande, Kevin J Petty, Margaret Fedgchin, Kristien van Dyck

Cancer Chemother Pharmacol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aprepitant: an oral NK1 antagonist for the prevention of nausea and vomiting induced by highly emetogenic chemotherapy.
Kelly Pendergrass, Richard Hargreaves, Kevin J Petty, Alexandra D Carides, Judith K Evans

Drugs Today (Barc)· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant.
Mats Bergström, Richard J Hargreaves, H Donald Burns, Michael R Goldberg, David Sciberras, Kevin J Petty

Biol Psychiatry· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of potential inductive effects of aprepitant on cytochrome P450 3A4 and 2C9 activity.
Craig R Shadle, Yih Lee, Anup K Majumdar, Kevin J Petty, Cynthia Gargano

J Clin Pharmacol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of etoricoxib in patients with renal impairment.
Nancy G B Agrawal, Catherine Z Matthews, Ralph S Mazenko, Walter F Kline, Eric J Woolf, Kevin J Petty

J Clin Pharmacol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of etoricoxib in patients with hepatic impairment.
Nancy G B Agrawal, Mark J Rose, Catherine Z Matthews, Eric J Woolf, Arturo G Porras, Kevin J Petty

J Clin Pharmacol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe.
Anup K Majumdar, Jacqueline B McCrea, Deborah L Panebianco, Michael Hesney, James Dru, Kevin J Petty

Clin Pharmacol Ther· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of aprepitant on digoxin pharmacokinetics in healthy subjects.
Martin Feuring, Yih Lee, Laura H Orlowski, Nicole Michiels, Marina De Smet, Kevin J Petty

J Clin Pharmacol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone.
Jacqueline B McCrea, Anup K Majumdar, Michael R Goldberg, Marian Iwamoto, Cynthia Gargano, Kevin J Petty

Clin Pharmacol Ther· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects.
Robert A Blum, Anup Majumdar, Jacqueline McCrea, John Busillo, Laura H Orlowski, Kevin J Petty

Clin Ther· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis